Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Cannabinoids and inflammation: Implications for People Living with HIV.

Costiniuk CT, Jenabian MA.

AIDS. 2019 Aug 12. doi: 10.1097/QAD.0000000000002345. [Epub ahead of print]

PMID:
31408029
2.

Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes.

Kumar V, Torben W, Mansfield J, Alvarez X, Vande Stouwe C, Li J, Byrareddy SN, Didier PJ, Pahar B, Molina PE, Mohan M.

Front Immunol. 2019 Apr 30;10:914. doi: 10.3389/fimmu.2019.00914. eCollection 2019.

3.

Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques.

Amedee AM, Nichols WA, LeCapitaine NJ, Stouwe CV, Birke LL, Lacour N, Winsauer PJ, Molina PE.

AIDS Res Hum Retroviruses. 2014 Dec;30(12):1216-25. doi: 10.1089/AID.2014.0108.

4.

Chronic Δ(9)-Tetrahydrocannabinol Administration Reduces IgE(+)B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin.

Wei Q, Liu L, Cong Z, Wu X, Wang H, Qin C, Molina P, Chen Z.

J Neuroimmune Pharmacol. 2016 Sep;11(3):584-591. doi: 10.1007/s11481-016-9674-9. Epub 2016 Apr 25.

5.

Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaques.

Chandra LC, Kumar V, Torben W, Vande Stouwe C, Winsauer P, Amedee A, Molina PE, Mohan M.

J Virol. 2015 Jan 15;89(2):1168-81. doi: 10.1128/JVI.01754-14. Epub 2014 Nov 5.

6.

Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.

Palesch D, Bosinger SE, Mavigner M, Billingsley JM, Mattingly C, Carnathan DG, Paiardini M, Chahroudi A, Vanderford TH, Silvestri G.

J Virol. 2018 Jun 29;92(14). pii: e00279-18. doi: 10.1128/JVI.00279-18. Print 2018 Jul 15.

8.

Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques.

Mavigner M, Habib J, Deleage C, Rosen E, Mattingly C, Bricker K, Kashuba A, Amblard F, Schinazi RF, Lawson B, Vanderford TH, Jean S, Cohen J, McGary C, Paiardini M, Wood MP, Sodora DL, Silvestri G, Estes J, Chahroudi A.

J Virol. 2018 Aug 29;92(18). pii: e00562-18. doi: 10.1128/JVI.00562-18. Print 2018 Sep 15. Erratum in: J Virol. 2019 Jan 17;93(3):.

9.

Δ9-Tetrahydrocannabinol suppresses monocyte-mediated astrocyte production of MCP-1 and IL-6 in a TLR7-stimulated human co-culture.

Rizzo MD, Crawford RB, Bach A, Sermet S, Amalfitano A, Kaminski NE.

J Pharmacol Exp Ther. 2019 Aug 5. pii: jpet.119.260661. doi: 10.1124/jpet.119.260661. [Epub ahead of print]

10.

Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques.

Malzahn J, Shen C, Caruso L, Ghosh P, Sankapal SR, Barratt-Boyes S, Gupta P, Chen Y.

Virol J. 2012 Nov 14;9:269. doi: 10.1186/1743-422X-9-269.

11.

Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.

Nganou-Makamdop K, Billingsley JM, Yaffe Z, O'Connor G, Tharp GK, Ransier A, Laboune F, Matus-Nicodemos R, Lerner A, Gharu L, Robertson JM, Ford ML, Schlapschy M, Kuhn N, Lensch A, Lifson J, Nason M, Skerra A, Schreiber G, Bosinger SE, Douek DC.

PLoS Pathog. 2018 Aug 24;14(8):e1007246. doi: 10.1371/journal.ppat.1007246. eCollection 2018 Aug.

12.

Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques.

Ryan ES, Micci L, Fromentin R, Paganini S, McGary CS, Easley K, Chomont N, Paiardini M.

PLoS Pathog. 2016 Feb 1;12(2):e1005412. doi: 10.1371/journal.ppat.1005412. eCollection 2016 Feb.

13.

Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis.

Molina PE, Amedee AM, LeCapitaine NJ, Zabaleta J, Mohan M, Winsauer PJ, Vande Stouwe C, McGoey RR, Auten MW, LaMotte L, Chandra LC, Birke LL.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):567-78. doi: 10.1089/AID.2013.0182. Epub 2014 Feb 7.

14.

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.

Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, Lebouché B, Cox J, Szabo J, Brouillette MJ, Klein MB, Chomont N, Jenabian MA.

BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793.

15.

Antibody-Mediated CD4 Depletion Induces Homeostatic CD4+ T Cell Proliferation without Detectable Virus Reactivation in Antiretroviral Therapy-Treated Simian Immunodeficiency Virus-Infected Macaques.

Kumar NA, McBrien JB, Carnathan DG, Mavigner M, Mattingly C, White ER, Viviano F, Bosinger SE, Chahroudi A, Silvestri G, Paiardini M, Vanderford TH.

J Virol. 2018 Oct 29;92(22). pii: e01235-18. doi: 10.1128/JVI.01235-18. Print 2018 Nov 15.

16.

Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.

Christensen-Quick A, Massanella M, Frick A, Rawlings SA, Spina C, Vargas-Meneses M, Schrier R, Nakazawa M, Anderson C, Gianella S.

J Virol. 2019 Jun 14;93(13). pii: e00179-19. doi: 10.1128/JVI.00179-19. Print 2019 Jul 1.

PMID:
31019052
17.

Initiation of Antiretroviral Therapy Restores CD4+ T Memory Stem Cell Homeostasis in Simian Immunodeficiency Virus-Infected Macaques.

Cartwright EK, Palesch D, Mavigner M, Paiardini M, Chahroudi A, Silvestri G.

J Virol. 2016 Jul 11;90(15):6699-6708. doi: 10.1128/JVI.00492-16. Print 2016 Aug 1.

18.

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.

Jaworowski A, Hearps AC, Angelovich TA, Hoy JF.

Front Immunol. 2019 Jun 19;10:1378. doi: 10.3389/fimmu.2019.01378. eCollection 2019. Review.

19.

Caspase-1-associated immune activation in an accelerated SIV-infected rhesus macaque model.

Kearns AC, Robinson JA, Shekarabi M, Liu F, Qin X, Burdo TH.

J Neurovirol. 2018 Aug;24(4):420-431. doi: 10.1007/s13365-018-0630-8. Epub 2018 Apr 2.

20.

Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.

Avalos CR, Abreu CM, Queen SE, Li M, Price S, Shirk EN, Engle EL, Forsyth E, Bullock BT, Mac Gabhann F, Wietgrefe SW, Haase AT, Zink MC, Mankowski JL, Clements JE, Gama L.

MBio. 2017 Aug 15;8(4). pii: e01186-17. doi: 10.1128/mBio.01186-17.

Supplemental Content

Support Center